Pharmacological treatment options in chronic heart failure

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorAbuirmaileh, Yahya
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-17T08:21:59Z
dc.date.available2022-08-17T08:21:59Z
dc.date.created2022-07-08
dc.description.abstractChronic heart failure treatment has been designs today to alleviate the symptoms of this disease, the cornerstone regimen is diuretics especially Lasix, ACE inhibitors and B-Blockers. Up-titrating ACE Antagonists as well as B-blockers to such substantial prescribed levels utilized with in controlled research studies seems critical. If such an ACE antagonist is really not accepted or has been inappropriate, an ARB should be started. The dosage as well as kind of diuretics (loop-acting, thiazide diuretics, or a mixture) are determined by the patient's fluid overload, creatinine levels, and the seriousness of underlying cardiovascular disease. If symptoms persist, sufferers should be prescribed an aldosterone inhibitor, an ARB, or even both. In addition to normal therapy, these medications had also shown to reduce morbidity and mortality.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent35 pageshu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336527
dc.language.isoenhu_HU
dc.subjectchronic heart failurehu_HU
dc.subject.dspaceDEENK Témalista::Medicinehu_HU
dc.titlePharmacological treatment options in chronic heart failurehu_HU
Fájlok